11/24
07:30 am
nspr
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
Low
Report
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
11/21
10:25 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/21
09:00 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/19
04:41 pm
nspr
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
High
Report
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
11/4
07:00 am
nspr
InspireMD Reports Third Quarter 2025 Financial Results
Medium
Report
InspireMD Reports Third Quarter 2025 Financial Results
11/3
07:30 am
nspr
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
Medium
Report
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
10/21
04:05 pm
nspr
InspireMD to Announce Third Quarter 2025 Financial Results
Medium
Report
InspireMD to Announce Third Quarter 2025 Financial Results
10/8
08:00 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/25
04:05 pm
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/22
02:34 am
nspr
Parkman Healthcare Expands Stake in InspireMD Backing Carotid Innovation [Yahoo! Finance]
Low
Report
Parkman Healthcare Expands Stake in InspireMD Backing Carotid Innovation [Yahoo! Finance]
9/17
08:00 am
nspr
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
Low
Report
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors